Cryptotanshinone promotes brown fat activity by AMPK activation to inhibit obesity
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVESActivating brown adipose tissue (BAT) and browning of white adipose tissue (WAT) can protect against obesity and obesity-related metabolic conditions. Cryptotanshinone (CT) regulates lipid metabolism and significantly ameliorates insulin resistance. Adenosine-5'-monophosphate (AMP)-activated protein kinase (AMPK), a receptor for cellular energy metabolism, is believed to regulate brown fat activity in humans. MATERIALS/METHODSThe in vivo study included high-fat-fed obese mice administered orally 200/400 mg/kg/d CT. They were evaluated through weight measurement, the intraperitoneal glucose tolerance test (IPGTT), intraperitoneal insulin tolerance test (IPITT), cold stimulation test, serum lipid (total cholesterol, triglycerides, and low-density lipoprotein) measurement, hematoxylin and eosin staining, and immunohistochemistry. Furthermore, the in vitro study investigated primary adipose mesenchymal stem cells (MSCs) with incubation of CT and AMPK agonists (acadesine)/inhibitor (Compound C). Cells were evaluated using Oil Red O staining, Alizarin red staining, flow cytometry, and immunofluorescence staining to identify and observe the osteogenic versus adipogenic differentiation. Quantitative real-time polymerase chain reaction and the Western blot were used to observe related gene expression. RESULTSIn the diet-induced obesity mouse model mice CT suppressed body weight, food intake, glucose levels in the IPGTT and IPTT, serum lipids, the volume of adipose tissue, and increased thermogenesis, uncoupling protein 1, and the AMPK pathway expression. In the in vitro study, CT prevented the formation of lipid droplets from MSCs while activating brown genes and the AMPK pathway. AMPK activator enhanced CT’s effects, while the AMPK inhibitor reversed the effects of CT. CONCLUSIONCT promotes adipose tissue browning to increase body thermogenesis and reduce obesity by activating the AMPK pathway. This study provides an experimental foundation for the use of CT in obesity treatment.
Abstract
BACKGROUND/OBJECTIVESActivating brown adipose tissue (BAT) and browning of white adipose tissue (WAT) can protect against obesity and obesity-related metabolic conditions. Cryptotanshinone (CT) regulates lipid metabolism and significantly ameliorates insulin resistance. Adenosine-5'-monophosphate (AMP)-activated protein kinase (AMPK), a receptor for cellular energy metabolism, is believed to regulate brown fat activity in humans. MATERIALS/METHODSThe in vivo study included high-fat-fed obese mice administered orally 200/400 mg/kg/d CT. They were evaluated through weight measurement, the intraperitoneal glucose tolerance test (IPGTT), intraperitoneal insulin tolerance test (IPITT), cold stimulation test, serum lipid (total cholesterol, triglycerides, and low-density lipoprotein) measurement, hematoxylin and eosin staining, and immunohistochemistry. Furthermore, the in vitro study investigated primary adipose mesenchymal stem cells (MSCs) with incubation of CT and AMPK agonists (acadesine)/inhibitor (Compound C). Cells were evaluated using Oil Red O staining, Alizarin red staining, flow cytometry, and immunofluorescence staining to identify and observe the osteogenic versus adipogenic differentiation. Quantitative real-time polymerase chain reaction and the Western blot were used to observe related gene expression. RESULTSIn the diet-induced obesity mouse model mice CT suppressed body weight, food intake, glucose levels in the IPGTT and IPTT, serum lipids, the volume of adipose tissue, and increased thermogenesis, uncoupling protein 1, and the AMPK pathway expression. In the in vitro study, CT prevented the formation of lipid droplets from MSCs while activating brown genes and the AMPK pathway. AMPK activator enhanced CT’s effects, while the AMPK inhibitor reversed the effects of CT. CONCLUSIONCT promotes adipose tissue browning to increase body thermogenesis and reduce obesity by activating the AMPK pathway. This study provides an experimental foundation for the use of CT in obesity treatment.
참고문헌 (45)
- Martínez-Vizcaíno V, "Diet in the management of weight loss", Nutrients, 13, pp.1306~ (2021)
- Diamantis DV, "Prevalence and socioeconomic correlates of adult obesity in Europe : the Feel4Diabetes study", Int J Environ Res Public Health, 19, pp.12572~ (2022)
- NCD Risk Factor Collaboration(NCD-RisC), "Worldwide trends in underweight and obesity from 1990 to 2022 : a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults", Lancet, 403, pp.1027~1050 (2024)
- Vandevijvere S, "Upstream determinants of overweight and obesity in Europe", Curr Obes Rep, 12, pp.417~428 (2023)
- Zhu J, "Obesity and dyslipidemia in chinese adults : a cross-sectional study in Shanghai, China", Nutrients, 14, pp.2321~ (2022)
- Sun X, "Health consequences of obesity and projected future obesity health burden in China", Obesity(Silver Spring), 30, pp.1724~1751 (2022)
- Reid TJ, "Medical and surgical treatment of obesity", Med Clin North Am, 106, pp.837~852 (2022)
- Müller TD, "Anti-obesity drug discovery : advances and challenges", Nat Rev Drug Discov, 21, pp.201~223 (2022)
- Perdomo CM, "Contemporary medical, device, and surgical therapies for obesity in adults", Lancet, 401, pp.1116~1130 (2023)
- Fink J, "Obesity surgery", Dtsch Arztebl Int, 119, pp.70~80 (2022)
- Zhu Q, "Mitochondrial regulation and white adipose tissue homeostasis", Trends Cell Biol, 32, pp.351~364 (2022)
- Li Y, "Uncoupling protein 1 does not produce heat without activation", Int J Mol Sci, 23, pp.2406~ (2022)
- Crichton PG, "The molecular features of uncoupling protein 1 support a conventional mitochondrial carrier-like mechanism", Biochimie, 134, pp.35~50 (2017)
- Scheele C, "Brown adipose crosstalk in tissue plasticity and human metabolism", Endocr Rev, 41, pp.53~65 (2020)
- Zhang F, "Electroacupuncture improves metabolic and ovarian function in a rat model of polycystic ovary syndrome by decreasing white adipose tissue, increasing brown adipose tissue, and modulating the gut microbiota", Acupunct Med, 40, pp.347~359 (2022)
- Cheng L, "Brown and beige adipose tissue : a novel therapeutic strategy for obesity and type 2 diabetes mellitus", Adipocyte, 10, pp.48~65 (2021)
- Saikia R, "a key regulator of energy stress and calcium-induced autophagy", J Mol Med(Berl), 99, pp.1539~1551 (2021)
- Steinberg GR, "New insights into activation and function of the AMPK", Nat Rev Mol Cell Biol, 24, pp.255~272 (2023)
- Desjardins EM, "Emerging role of AMPK in brown and beige adipose tissue(BAT) : implications for obesity, insulin resistance, and type 2 diabetes", Curr Diab Rep, 18, pp.80~ (2018)
- Szewczuk M, "The role of AMPK in metabolism and its influence on DNA damage repair", Mol Biol Rep, 47, pp.9075~9086 (2020)
- Wu YH, "Cryptotanshinone : a review of its pharmacology activities and molecular mechanisms", Fitoterapia, 145, pp.104633~ (2020)
- Wang L, "Cryptotanshinone alleviates chemotherapy-induced colitis in mice with colon cancer via regulating fecal-bacteria-related lipid metabolism", Pharmacol Res, 163, pp.105232~ (2021)
- Terado T, "Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS-activated pancreatic cancer cells", Int J Oncol, 61, pp.108~ (2022)
- Imran KM, "Cryptotanshinone promotes commitment to the brown adipocyte lineage and mitochondrial biogenesis in C3H10T1", 2 mesenchymal stem cells via AMPK and p38-MAPK signaling, 2017, pp.1862, 1110~1120
- Yang W, "Cryptotanshinone suppressed postmenopausal osteoporosis by preventing RANKL-mediated osteoclastogenesis against kidney injury", Evid Based Complement Alternat Med, 2022, pp.2821984~ (2022)
- Wang N, "Effect of cryptotanshinone on glucose and lipid metabolism and sex hormone levels of rats with polycystic ovary syndrome", Matern Child Health Care China, 30, pp.3490~3493 (2015)
- Ling J, "Perfluorooctane sulfonate promotes hepatic lipid accumulation and steatosis in high-fat diet mice through AMP-activated protein kinase", acetyl-CoA carboxylase(AMPK, J Appl Toxicol, pp.2023, 43[DOI]
- Villarroya F, "Inflammation of brown", beige adipose tissues in obesity and metabolic disease, 2018, pp.284, 492~504
- Carpi S, "Tanshinone IIA and Cryptotanshinone counteract inflammation by regulating gene and miRNA expression in human SGBS adipocytes", Biomolecules, 13, pp.1029~ (2023)
- Song M, "Cryptotanshinone enhances wound healing in type 2 diabetes with modulatory effects on inflammation, angiogenesis and extracellular matrix remodelling", Pharm Biol, 58, pp.845~853 (2020)
- Tang H, "Kaempferide improves glycolipid metabolism disorder by activating PPARγ in high-fat-diet-fed mice", Life Sci, 270, pp.119133~ (2021)
- Zhang S, "Naringenin activates beige adipocyte browning in high fat diet-fed C57BL", 6 mice by shaping the gut microbiota, 2022, pp.13, 9918~9930
- Wang X, "New developments in the chemistry and biology of the bioactive constituents of Tanshen", Med Res Rev, 27, pp.133~148 (2007)
- Deng X, "Development and structure-activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors", Nat Prod Bioprospect, 12, pp.36~ (2022)
- Wang Q, "Post-translational control of beige fat biogenesis by PRDM16 stabilization", Nature, 609, pp.151~158 (2022)
- Chouchani ET, "New advances in adaptive thermogenesis : UCP1 and beyond", Cell Metab, 29, pp.27~37 (2019)
- van der Vaart JI, "The role of AMPK signaling in brown adipose tissue activation", Cells, 10, pp.1122~ (2021)
- Ding X, "Chicoric acid ameliorates nonalcoholic fatty liver disease via the AMPK", Nrf2, Oxid Med Cell Longev, pp.2020, 2020[DOI]
- Hu M, "Salidroside activates the AMP-activated protein kinase pathway to suppress nonalcoholic steatohepatitis in mice", Hepatology, 74, pp.3056~3073 (2021)
- Entezari M, "AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications : a pre-clinical and clinical investigation", Biomed Pharmacother, 146, pp.112563~ (2022)
- Zhang E, "Intestinal AMPK modulation of microbiota mediates crosstalk with brown fat to control thermogenesis", Nat Commun, 13, pp.1135~ (2022)
- Diniz TA, "Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice", Life Sci, 266, pp.118868~ (2021)
- Nagappan A, "Cryptotanshinone from the Salvia miltiorrhiza bunge attenuates ethanol-induced liver injury by activation of AMPK", SIRT1 and Nrf2 signaling pathways, 2019, pp.21, 265~
- Chen J, "E2F1 regulates adipocyte differentiation and adipogenesis by activating ICAT", Cells, 9, pp.1024~ (2020)
- Wang YL, "Concomitant beige adipocyte differentiation upon induction of mesenchymal stem cells into brown adipocytes", Biochem Biophys Res Commun, 478, pp.689~695 (2016)